Avita Medical is a medical devices business based in Australia. Avita Medical shares (AVH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Avita Medical has a trailing 12-month revenue of around $50.1 million. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Avita Medical, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $2.58 - $6.27 |
|---|---|
| 50-day moving average | $4.4188 |
| 200-day moving average | $4.356 |
| Target price | $4.68 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.43 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$2.78
| 1 week (2024-05-01) | 5.70% |
|---|---|
| 1 month (2024-04-09) | -39.30% |
| 3 months (2024-02-09) | -48.61% |
| 6 months (2023-11-09) | -12.58% |
| 1 year (2023-05-09) | -40.60% |
|---|---|
| 2 years (2022-05-09) | 68.48% |
| 3 years (2021-05-07) | -43.72% |
| 5 years (2019-05-09) | -98.24% |
| Revenue TTM | $50.1 million |
|---|---|
| Gross profit TTM | $28.4 million |
| Return on assets TTM | -25.35% |
| Return on equity TTM | -52.89% |
| Profit margin | -70.56% |
| Book value | 1.91 |
| Market capitalisation | $352.2 million |
TTM: trailing 12 months
We're not expecting Avita Medical to pay a dividend over the next 12 months.
Avita Medical's shares were split on a 5:100 basis on 23 June 2020. So if you had owned 100 shares the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Avita Medical shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Avita Medical shares which in turn could have impacted Avita Medical's share price.
Over the last 12 months, Avita Medical's shares have ranged in value from as little as $2.58 up to $6.27. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Avita Medical's is 1.291. This would suggest that Avita Medical's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
AMP Ltd Preferred
AUD104.85
ANZ Group Holdings Ltd. Pfd.
AUD101.63
ANZ Group Holdings Ltd. Pfd.
AUD103.53
Challenger Ltd Preferred
AUD105.94
Macquarie Bank Ltd Pref
AUD106.56
Macquarie Group Ltd Pref C
AUD103.69
Macquarie Group Limited
AUD106.99
Suncorp Group Ltd Pref
AUD100.50
Westpac Banking Corp Pref
AUD104.10
Explore Spaceship's US Investing service: low entry cost with a focus, but limited trading options.
Explore our comprehensive review of HALO Trading's features and fees for Australian traders.
We used a proprietary algorithm to find the a list of ASX penny stocks that should be on your watchlist in 2024.
Looking for the best performing stocks in Australia? We update this list weekly.
Here's all the key information you need to know to sell shares you inherited or received as a gift.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
$1,000 is a great place to start investing – these are your options.
CMC Invest account features brokerage from as low as $9.90 and a host of research and market data options.
The Finder review of the Bank of Melbourne directshares Online Broking platform.
Access Australian shares and ETFs at home or on-the-go with a Macquarie Online Trading account.